Cargando…
Discovery of TCMs and derivatives against the main protease of SARS-CoV-2 via high throughput screening, ADMET analysis, and inhibition assay in vitro
The rapidly evolving Coronavirus Disease 2019 (COVID-19) pandemic caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has spread worldwide with thousands of deaths and infected cases. For the identification of effective treatments against this disease, the main protease (M(pro...
Autores principales: | Qi, Xinyu, Li, Binglin, Omarini, Alejandra B., Gand, Martin, Zhang, Xiaoli, Wang, Jiao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier B.V.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9273959/ https://www.ncbi.nlm.nih.gov/pubmed/35846732 http://dx.doi.org/10.1016/j.molstruc.2022.133709 |
Ejemplares similares
-
Discovery of genistein derivatives as potential SARS-CoV-2 main protease inhibitors by virtual screening, molecular dynamics simulations and ADMET analysis
por: Liu, Jiawei, et al.
Publicado: (2022) -
In silico Approach for Anti-Thrombosis Drug Discovery: P2Y(1)R Structure-Based TCMs Screening
por: Yi, Fan, et al.
Publicado: (2017) -
Proteomic Analysis of Anticancer TCMs Targeted at Mitochondria
por: Wang, Yang, et al.
Publicado: (2015) -
Target-based drug discovery, ADMET profiling and bioactivity studies of antibiotics as potential inhibitors of SARS-CoV-2 main protease (M(pro))
por: Abdul-Hammed, Misbaudeen, et al.
Publicado: (2021) -
Molecular docking and ADMET study of bioactive compounds of Glycyrrhiza glabra against main protease of SARS-CoV2
por: Srivastava, Vivek, et al.
Publicado: (2022)